Author

Ateret Revital

Hebrew University of Jerusalem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

Liraz KlausneriD· 2 shared Shai CarmiiD· 2 shared Todd LencziD· 2 shared Alberto VaiarelliiD· 1 shared Antonio CapalboiD· 1 shared Christian Simon OttoliniiD· 1 shared Danilo CimadomoiD· 1 shared Elvezia Maria ParaboschiiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Liraz KlausnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PEStimate: Predicting offspring disease risk after Polygenic Embryo Screening

Liraz Klausner, Ateret Revital, Todd Lencz, Shai Carmi

PEStimate predicts offspring disease risk after polygenic embryo screening by modeling risk reduction and accounting for embryo implantation failure.

Bioinformatics · May 12, 2026Peer-reviewedGenetic & Genomic Medicine

Modeling polygenic embryo screening in real-world IVF patients demonstrates limitations on efficacy

Liraz Klausner, Elvezia Maria Paraboschi, Francesca Mulas, Ludovica Picchetta, Christian Simon Ottolini, Ateret Revital, Danilo Cimadomo, Alberto Vaiarelli, Todd Lencz, Antonio Capalbo, Shai Carmi

This paper models polygenic embryo screening (PES) in IVF patients and finds it leads to small relative risk reductions in most cases due to low live birth rates and limited embryo availability.

medRxiv · Apr 20, 2026 · PreprintGenetic & Genomic Medicine